Can I read High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week on EtoBox?

High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week by XIAO; LIU; HU; XIA; TYTGAT is a Medicine article available to read on EtoBox.

What is High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week about?

## Background: When metronidazole is used in bismuth‐based or proton pump inhibitor‐based triple therapy, the cure rate of __Helicobacter pylori__ is usually high. However, metronidazole‐resistant __H. pylori__ strains, which are increasing in frequency, are a major cause of failed __H.␣pylori__ eradication. ## Aim: To evaluate the efficacy of non‐metronidazole containing bismuth‐based triple therapy for __H. pylori__ infection. ## Methods: One‐hundred and eighty __H. pylori__‐positive patients with endoscopically documented peptic ulcer disease or functional dyspepsia were randomly assigned to one of three 1‐week regimens containing tripotassium dicitrato bismuthate (also called colloidal bismuth subcitrate) 240 mg b.d. and two antibiotics: furazolidone 100 mg b.d. plus clarithromycin 250 mg b.d. (Group A); or clarithromycin 250 mg b.d. plus amoxycillin 1000 mg b.d. (Group B); or furazolidone 100 mg b.d. plus josamycin 1000 mg b.d. (Group C). __H. pylori__ status was assessed by rapid urease test, histology and culture of gastric biopsy specimens taken from both the antrum and corpus, both before and at least 4 weeks after completion of therapy. ## Results: Thirteen patients dropp

Who reads High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week?

Author

XIAO; LIU; HU; XIA; TYTGAT

Publisher

John Wiley and Sons; Blackwell Publishing; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Wiley; Research Square (ISSN 0269-2813)

Published

1999

Language

EN

Field

Medicine (Health Sciences)